Antibiogram software for Cerner and Oracle Health hospitals, when the Millennium microbiology report is enough, and when to buy a separate tool
Oracle Health Microbiology can print an antibiogram, and the certified AUR package adds a stewardship worklist. What it does not guarantee is a CLSI M39 first-isolate count. Here are the routes a Cerner hospital actually has, and what each one costs.
8 min read
A Cerner hospital has four realistic ways to get a cumulative antibiogram: the antibiogram report built into Oracle Health Microbiology, a custom Discern Explorer (CCL) report, an enterprise surveillance platform interfaced to Millennium, or a separate antibiogram tool fed by a susceptibility export. The native report is the cheapest to start, but its duplicate-isolate logic is configurable and has historically differed from the CLSI M39 first-isolate rule, so check it before the P and T committee relies on it.
This is written for the stewardship pharmacist, microbiology lead or pharmacy director at a hospital on Oracle Health Foundation EHR, the name Oracle now uses for Cerner Millennium, who owns the annual antibiogram and has no analyst assigned to it. Oracle Health is described only from its own public pages and from published papers.
What Oracle Health gives you for the antibiogram
Oracle closed its roughly $28.3 billion acquisition of Cerner in June 2022, and the platform is now sold as Oracle Health. Its laboratory brochure says Oracle Health Microbiology offers online reporting that generates antibiograms, statistics, historical data and infection control reports. Its infection control page adds that clinicians can evaluate medication usage, antibiograms and stewardship effectiveness with Pharmacy Clinical Surveillance reporting.
For NHSN, Oracle certifies a separate product, Oracle Health Antimicrobial Usage and Resistance Reporting. Its ONC disclosure lists what a hospital must license to use it: PowerChart, Pharmacy Inpatient, a medication administration record, Microbiology or a discrete microbiology interface, Discern Explorer and an AUR reporting extract subscription, with an MPages Antimicrobial Stewardship Worklist as an option. That is the AUR half of the job. The cumulative antibiogram is still whatever your microbiology build produces.
Do not confuse either with the Personal Antibiogram in PowerChart. That view lines up susceptibility results for one patient across several cultures. It is useful at the bedside and says nothing about your hospital's resistance rates.
Where the Millennium antibiogram can differ from CLSI M39
The detail that matters most is how duplicates are removed. CLSI M39 counts the first isolate of each species per patient per analysis period, regardless of its susceptibility pattern. A University of Kentucky study (White and colleagues, Diagnostic Microbiology and Infectious Disease, 2001) compared methods and found that Cerner defined a duplicate as the same patient, the same species and the same susceptibility category to an individual drug. Because a repeat isolate with a changed result then counts as new, the Cerner figures differed from the other methods by minus 11 to plus 25 percent, and Cerner's method produced the highest percent susceptible most often.
That study is 25 years old and every Millennium build is configured locally, so it does not tell you what your report does today. It tells you which question to ask. The second trap is cascade reporting. A 2018 American Journal of Clinical Pathology abstract describes a lab that pulled a generic Cerner Millennium report and wrote R code to parse it, partly because cascade rules suppress results for secondary agents. Count only the released results and the second-line drugs in your antibiogram rest on a biased subset of isolates.
The Discern Explorer route, and why it stalls
Anything Millennium stores can be reported with Discern Explorer, Cerner's CCL query language, so a custom antibiogram is always technically possible. The obstacle is people. A 2014 Clinical Infectious Diseases paper on building stewardship tools in PowerChart put it plainly: out of the box functionality for stewardship is limited, and significant hospital information technology resources are needed to extend it. A CCL antibiogram has to implement first-isolate de-duplication, the 30-isolate suppression rule, intermediate handling and the breakpoint version, and it has to be revalidated whenever the lab changes a panel.
The cheaper pattern is to ask the Discern analyst for one flat extract instead of a finished report: a susceptibility line list written to a secure folder each quarter. If several systems have to consume that file, a data integration platform can move it on a schedule without another custom job in the IT queue. The columns a line list needs are listed on the LIS susceptibility export page.
Antibiogram routes for a Cerner hospital, side by side
| Route | Who builds and maintains it | M39 first isolate and suppression | Cost |
|---|---|---|---|
| Oracle Health Microbiology antibiogram report | Lab and Millennium build staff | Depends on the duplicate setting; verify it | Included with Microbiology |
| Custom Discern Explorer (CCL) report | Your Discern analysts, on their queue | Whatever the specification says | No new license, analyst weeks |
| Oracle Health AUR reporting package | Oracle and your IT | Built for NHSN AUR, not the local antibiogram | AUR extract subscription plus required licenses |
| Enterprise surveillance platform | Vendor implementation with your IT | Ask the vendor to show the method | Not published |
| WHONET fed by a lab export | One person on a Windows PC | Yes, once configured | Free software, your hours |
| Antimicrobe fed by a lab export | The stewardship team, in a browser | Yes, applied automatically with counts shown | $249 a month (Lab) or $749 (Stewardship) |
Is the Cerner antibiogram good enough for CLSI M39?
It can be, if duplicates and cascades are handled to M39. A Cerner antibiogram meets CLSI M39 when it counts the first isolate per patient per species in the period regardless of susceptibility, suppresses cells under 30 isolates, includes suppressed cascade results or states that it excludes them, and prints the breakpoint version. Ask your Millennium build team which duplicate rule is switched on.
A quick test works without anyone touching the build. Take the report's Klebsiella pneumoniae row and count unique patients with a K. pneumoniae isolate in the same year from a line list. If the report shows noticeably more isolates than patients, repeat cultures are being counted, and the percentages lean toward whichever patients were cultured most.
How much does it cost to build an antibiogram in Cerner?
The license cost is usually zero, because Microbiology and Discern Explorer are already owned. The real cost is analyst time: specifying the report to M39, validating it against a manual count, and repeating that after upgrades, panel changes and breakpoint revisions. Hospitals on a hosted Oracle Health contract often need a service request for any custom report, which adds weeks.
A monthly tool moves that work out of the queue. Antimicrobe is $249 a month for one facility on the Lab plan, bought by card, or $749 a month for up to three facilities with unit cuts, quarterly trends and MDRO threshold alerts. The input is the quarterly CSV line list: patient or MRN, collection date, specimen source, unit, organism, antibiotic and S, I or R, with suppressed cascade results included if the lab can export them.
The full comparison across enterprise platforms, free tools and our plans is in how much antibiogram software costs.
CommunityWorks and smaller Oracle Health hospitals
Oracle Health is the second-largest US acute care EHR vendor. KLAS put it at 21.9 percent of US hospitals in its 2026 market share report, with its recent losses heaviest among small health systems. Many of the hospitals that stay are community and critical access hospitals on CommunityWorks, the cloud-based, multi-tenant deployment of Millennium built for community, critical access and specialty hospitals.
On a shared platform the local IT team rarely controls custom report builds, and there is usually no Discern analyst on site at all. For those hospitals the practical path is a standard microbiology extract to CSV once a quarter, with the antibiogram built outside Millennium where the method is visible and identical every year.
Small isolate counts change how that report has to be built, which the critical access hospital antibiogram page covers in detail.
Which route fits which Oracle Health hospital
A large Millennium hospital with Discern analysts who already maintain microbiology reports should keep the antibiogram in house and spend a day confirming the duplicate rule and cascade handling against M39. When the people exist and stay, that is the cheapest route.
A community or CommunityWorks hospital whose build requests wait on a hosted queue usually does better with a quarterly export into a $249 a month tool, because the analyst hours cost more than the subscription. Hospitals that also need real-time stewardship alerts and NHSN AUR submission should evaluate Oracle's own AUR package or a surveillance platform, and can still keep the antibiogram separate.
If you are comparing surveillance platforms for that second job, start with Sentri7 alternatives and competitors. Sister guides cover the same decision for antibiogram software for Epic hospitals and antibiogram software for MEDITECH hospitals.
Questions to ask your Millennium team before buying anything
- Where does our current antibiogram come from: the Microbiology report, a Discern Explorer query or a spreadsheet?
- Which duplicate-isolate rule is configured, and does a resistant repeat isolate count as a new isolate?
- Are results suppressed by cascade rules included in the percentages, excluded, or flagged?
- Does the report suppress cells under 30 isolates, and which CLSI breakpoint version does it apply?
- Who validates it after a panel change, an upgrade or a breakpoint revision, and when was that last done?
- Can the lab export a susceptibility line list as CSV each quarter, including suppressed results?
Related on this site: LIS susceptibility export, hospital antibiogram software, critical access hospital antibiogram, CLSI and EUCAST breakpoints.